Marker Therapeutics, Inc. - Common Stock, Par Value $0.001 (MRKR) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2018 to Q2 2025

Type / Class
Equity / Common Stock, Par Value $0.001
Symbol
MRKR on Nasdaq
Shares outstanding
12,939,536
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Marker Therapeutics, Inc. - Common Stock, Par Value $0.001 (MRKR) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Wilson John Robert 5% -2.8% 641,801 -2.7% John R. Wilson TTE, John R. Wilson Revocable Trust U/A DTD 08/03/2017 19 Aug 2025

Institutional Holders of Marker Therapeutics, Inc. - Common Stock, Par Value $0.001 (MRKR) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q2 0 $0 -$91,000 0
2025 Q1 73,700 $91,000 $1.23 1
2024 Q4 73,700 $229,000 $3.11 1
2024 Q3 73,700 $208,000 +$8,467 $2.82 1
2024 Q2 70,700 $384,000 $5.43 1
2024 Q1 70,700 $304,000 $4.30 1
2023 Q4 70,700 $389,000 $5.50 1
2023 Q3 70,700 $321,000 +$136,209 $4.54 1
2023 Q2 40,700 $126,000 -$223,143 $3.10 1
2023 Q1 354,986 $252,143 -$6,332,147 $0.71 2
2022 Q4 19,546,105 $5,208,334 -$195,948 $0.27 43
2022 Q3 20,427,696 $7,535,895 -$658,822 $0.37 37
2022 Q2 22,253,013 $7,342,065 -$411,733 $0.33 39
2022 Q1 23,310,733 $10,256,450 -$2,487,613 $0.44 42
2021 Q4 26,461,278 $25,140,343 -$1,342,196 $0.95 60
2021 Q3 26,412,576 $44,633,950 -$1,704,437 $1.69 58
2021 Q2 27,173,367 $75,812,484 +$4,097,469 $2.79 69
2021 Q1 25,400,713 $56,885,831 +$25,805,391 $2.24 72
2020 Q4 14,076,479 $20,411,792 -$85,175 $1.45 57
2020 Q3 14,125,971 $21,191,654 -$280,215 $1.50 56
2020 Q2 14,203,158 $29,397,996 -$1,430,219 $2.07 60
2020 Q1 14,891,509 $28,290,907 -$1,428,036 $1.90 59
2019 Q4 15,449,518 $44,457,051 -$10,911,286 $2.88 63
2019 Q3 17,136,981 $87,562,375 -$1,565,828 $5.11 71
2019 Q2 16,861,538 $133,539,372 +$13,355,215 $7.92 67
2019 Q1 15,300,000 $100,980,170 -$154,139 $6.60 53
2018 Q4 15,576,080 $86,448,000 +$75,184,349 $5.55 39
2018 Q3 3,563 $32,000 +$32,000 $8.98 1